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Background and Purpose We developed a novel method named Gray-matter Volume Esti-
mate Score (GRAVES), measuring early ischemic changes on Computed Tomography (CT) 
semi-automatically by computer software. This study aimed to compare GRAVES and Alber-
ta Stroke Program Early CT Score (ASPECTS) with regards to outcome prediction and inter-
rater agreement.
Methods This was a retrospective cohort study. Among consecutive patients with ischemic 
stroke in the anterior circulation who received intra-arterial therapy (IAT), those with a 
readable pretreatment CT were included. Two stroke neurologists independently measured 
both the GRAVES and ASPECTS. GRAVES was defined as the percentage of estimated hy-
podense lesion in the gray matter of the ipsilateral hemisphere. Spearman correlation anal-
ysis, receiver operating characteristic (ROC) comparison test, and intra-class correlation co-
efficient (ICC) comparison tests were performed between GRAVES and ASPECTS.
Results Ninety-four subjects (age: 68.7±10.3; male: 54 [54.9%]) were enrolled. The mean 
GRAVES was 9.0±8.9 and the median ASPECTS was 8 (interquartile range, 6-9). Correlation 
between ASPECTS and GRAVES was good (Spearman’s rank correlation coefficient, 0.642; 
P<0.001). ROC comparison analysis showed that the predictive value of GRAVES for favor-
able outcome was not significantly different from that of ASPECTS (area under curve, 0.765 
vs. 0.717; P=0.308). ICC comparison analysis revealed that inter-rater agreement of GRAVES 
was significantly better than that of ASPECTS (0.978 vs. 0.895; P<0.001).
Conclusions GRAVES had a good correlation with ASPECTS. GRAVES was as good as AS-
PECTS in predicting a favorable clinical outcome, but was better than ASPECTS regarding 
inter-rater agreement. GRAVES may be used to predict the outcome of IAT.
Keywords Acute ischemic stroke; Acute stroke imaging; Computed tomography; ASPECTS; 
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Introduction
Early ischemic changes (EIC) on Computed Tomography 
(CT) represent early cytotoxic edema and possible develop-
ment of irreversible tissue injury.1,2 As reperfusion to irreversibly 
injured tissue is not beneficial and can even be harmful if it leads 
to hemorrhage, European Cooperative Acute Stroke Study trials 
have excluded patients with EIC involving more than a third of 
the middle cerebral artery territory on CT.3-5 However, this 
method is not reliable even by experienced clinicians.6 There-
fore, to improve the reliability of EIC measurement, the Alberta 
Stroke Program Early CT Score (ASPECTS), a systematic 
method quantifying EIC, was devised.7 ASPECTS has proved 
its worth in predicting outcomes of reperfusion therapy in acute 
ischemic stroke,7-12 and was used to exclude patients with large 
infarct core in the recently published trials which showed clear 
benefit of intra-arterial therapy (IAT). 
Nevertheless, highly trained personnel are required to measure 
ASPECTS and there have been conflicting reports of inter-rater 
agreement.7,13-17 Therefore, we have developed a novel method 
named Gray-matter Volume Estimate Score (GRAVES), which is 
expected to have better reliability as it is a semi-automatic method 
of measuring EIC on CT using computer software. The object of 
this study was to compare GRAVES and ASPECTS with regards 
to outcome prediction and inter-rater agreement 
Methods
Patients
This was a retrospective cohort study. Candidates for this 
study were consecutive patients with ischemic stroke in the uni-
lateral anterior circulation who received IAT between January 
2009 and May 2012, at our institute. All those with a readable 
baseline CT were included. The local institutional review board 
approved this study and granted a waiver of consent because of 
its retrospective nature.
Reperfusion therapy protocol and follow-up
Our reperfusion therapy and imaging protocols have been 
published previously.18,19 Briefly, patients presenting within 3 
hours of stroke onset were treated with intravenous tissue plas-
minogen activator (IV tPA) (Actylase; Boehringer-Ingelheim, 
Ingelheim, Germany) at a standard dose of 0.9 mg/kg (10% as 
bolus then 90% as an infusion for 60 minutes) after Non-contrast 
Computed Tomography (NCCT). If patients showed an unsat-
isfactory clinical response (defined as a < 50% improvement as 
measured by the National Institutes of Health Stroke Scale [NI-
HSS]) at the end of IV tPA infusion, IAT was considered after 
follow-up NCCT with CT angiography. Those patients who 
presented between 3-6 hours of stroke onset were also consid-
ered for IAT after NCCT with CT angiography. Reperfusion 
was graded by the Thrombolysis in Cerebral Infarction scale. 
Successful reperfusion was defined as Thrombolysis in Cerebral 
Infarction 2b or 3. The modified Rankin Score was assessed at 3 
months after stroke onset. Favorable outcome was defined as 
modified Rankin Score ≤ 2 at 3 months. 
Imaging acquisition
NCCT images were obtained on a multi-detector row CT sys-
tem (Sensation 64; Siemens, Erlangen, Germany or LightSpeed 
Plus; GE Healthcare, Milwaukee, WI, USA). The sequential axi-
al 3-mm NCCT (Sensation 64) was performed with the follow-
ing parameters: 120 kVp, 300 mAs, field of view of 250 mm, 1 s/
rotation, 30 × 0.6 mm collimation and a H30s medium recon-
struction kernel. The sequential axial 5-mm NCCT (LightSpeed 
Plus) was performed with the following parameters: 120 kVp, 
250 mAs, field of view of 250 mm, 0.8 s/rotation, 4 × 1.25 mm 
collimation, and a smooth reconstruction kernel. 
NCCT analysis using GRAVES and ASPECTS 
To measure EIC, CT scans taken just before IAT were ana-
lyzed. Two stroke neurologists independently reviewed CT 
scans and measured GRAVES and ASPECTS blinded to clini-
cal information except stroke side. Any discrepancy between 
the two readers was resolved by reaching a consensus.
GRAVES was developed based on the software platform for 
image analysis (Xelis; INFINITT Healthcare, Seoul, Korea). 
GRAVES was defined as the estimated percentage of hypodense 
lesion in the gray matter of symptomatic hemisphere. With an 
assumption that contralateral hemisphere is normal and that 
two hemispheres are relatively symmetric, GRAVES was mea-
sured by subtracting estimated area of normal gray matter in the 
symptomatic hemisphere (GMsymptomatic) from that in the contra-
lateral hemisphere (GMcontralateral; GRAVES = [GMcontralateral-GM 
symptomatic]/[GMcontralateral] × 100). Estimated area of normal gray 
matter was operationally defined as an area of which Hounsfield 
unit (HU) is between the mean HU of the contralateral normal 
caudate head (HUcaudate) and HUcaudate+9. In case of an abnormal 
contralateral caudate head, another normal structure of the con-
tralateral deep gray matter such as the thalamus or lentiform nu-
cleus was selected, at the discretion of the rater. To reflect area 
asymmetry between the hemispheres, estimated areas of normal 
brain parenchyme in each hemisphere (Parenchymesymptomatic and 
Parenchymecontralateral) predefined as area of which HU is between 
20 and 55, were used for adjustment (Adjusted GMcontralateral =  
GMcontralateral*[Parenchymesymptomatic/Parenchymecontralateral]). CT 
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Figure 1. Representative figures of GRAVES measurements. Representative 
measurements of GRAVES in a patient with large core (GRAVES, 19.75; AS-
PECTS, 1; A and B), moderate core (GRAVES, 12.93; ASPECTS, 6; C, D), and 
small core (GRAVES, 1.92; ASPECTS, 10; E and F) are shown. Central lines that 
separate the hemispheres are drawn automatically and can be adjusted by a 
rater. The reference values of Hounsfield unit (HU) for the gray matter are de-
termined by drawing a region of interest on the contralateral caudate head 
(yellow-colored area indicated arrow; A, C, and E). Then, computer software 
automatically analyzes the mean HU of region of interest. Red colored pixels 
are the area of which the values of HU are between the mean HU of the con-
tralateral caudate head (HUcaudate) and HUcaudate + 9. These represent estimated 
normal gray matter. Blue-colored pixels are the area of which the values of HU 
are between 20 and 55. These represent estimated normal brain parenchyme 
(B, D, and F). GRAVES, Gray-matter Volume Estimate Score; ASPECTS, Alberta 
Stroke Program Early CT Score. 
slices that cover 60 mm from upper midbrain (superior collicu-
lus) level were all included for analysis (e.g. 20 axial slices in 
3-mm NCCT, and 12 axial slices in 5-mm NCCT). To measure 
GRAVES, raters set the range of axial CT slices to analyze, ad-
justed the central line separating the hemispheres, and drew the 
ROI on the contralateral caudate head. After the stated simple 
steps, computer software calculates GRAVES automatically and 
reports immediately (Figure 1).
ASPECTS was measured following recently modified defini-
tion of EIC.20 Tissue hypoattenuation and loss of gray–white 
matter differentiation, but not isolated cortical swelling, were 
taken as evidence for EIC. All axial CT images were used and 
settings for the window level were adjusted at the discretion of 
the rater to increase contrast between normal and ischemic 
brain areas. 
Statistical analysis
Values were presented as number (%), mean ± standard devi-
ation or median (interquartile range [IQR]) as appropriate. 
Univariate analyses (independent sample t-test or Mann-Whit-
ney U test for continuous variables and χ2 test or Fisher’s exact 
test for categorical variables as appropriate) were performed to 
compare baseline characteristics, treatment modalities, time pa-
rameters, and imaging characteristics between the favorable and 
the unfavorable outcome groups. Variables achieving a P value 
less than 0.05 in the univariate analyses for favorable outcome 
were adjusted for the multivariate analyses (binary logistic re-
gression models with favorable outcome as the dependent vari-
able). Spearman correlation analysis between ASPECTS and 
GRAVES was performed. Receiver operating characteristic 
(ROC) comparison test was performed to compare predictabil-
ity of a favorable outcome between ASPECTS and GRAVES. 
The Youden index was used to determine the optimal cut-off 
value of ASPECTS and GRAVES. Inter-rater agreements were 
assessed with linear-weighted κ statistics, intra-class correlation 
coefficient (ICC) and Bland-Altman plot. ICC comparison test 
was performed to compare inter-rater agreement of ASPECTS 
and that of GRAVES. Statistical analyses were performed using 
the IBM SPSS Statistics for Windows Version 20.0 (IBM Corp., 
Armonk, NY, USA) and MedCalc (MedCalc, Mariakerke, Bel-
gium). A two-sided P value of < 0.05 was considered statistical-
ly significant.
Results
Patients enrollment 
A total of 250 patients with acute ischemic stroke received IV 
tPA and/or IAT at our institute between January 2009 and May 
2012. Of these, 155 who received IAT were considered for in-
clusion in this study. Among the 155 patients, we excluded 25 
with posterior circulation infarction, 3 with bilateral infarctions, 
8 with unavailable modified Rankin Score at 3 months, 2 pa-
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tients with unavailable baseline CT and 23 with unreadable CT 
(12 with old territorial infarction, 10 with motion artifact, and 1 
with brain tumor). Finally, 94 patients were enrolled in this 
study.
Baseline characteristics
Mean age of the study subjects was 68.7 ± 10.3 years and 54 
(57.4%) were men. The median NIHSS score at admission was 
16 (IQR, 12-20). The median GRAVES of all subjects, internal 
carotid artery occlusion, middle cerebral artery M1 occlusion, 
and M2 occlusion was 6.2 (IQR, 2.4-13.8), 8.6 (IQR, 2.4-
15.5), 6.1 (IQR, 2.5-16.0), and 5.0 (IQR, -0.5-9.5), respective-
ly. The median ASPECTS of all subjects,  internal carotid artery 
occlusion, middle cerebral artery M1 occlusion, and middle ce-
rebral artery M2 occlusion was 8 (IQR, 6-9), 7 (IQR, 3-9), 8 
(IQR, 6-10), and 9 (IQR, 7-10), respectively. We treated 58 
(61.2%) patients with combined IV tPA and IAT, and 36 
(38.8%) with IAT only. Successful reperfusion was achieved in 
59 (62.8%) patients, and 44 (48.9%) had a favorable outcome. 
Correlation between GRAVES and ASPECTS
Correlation between GRAVES and ASPECTS was good 
(Spearman’s rank correlation coefficient, -0.642; P < 0.001; 
Figure 2).
Outcome prediction of GRAVES and ASPECTS
The favorable outcome group had significantly less hyperten-
sion, less atrial fibrillation, lower NIHSS, more initial M2 occlu-
sion, more initial IAT with Solitaire, more successful reperfusion, 
lower GRAVES, and higher ASPECTS compared to the unfa-
vorable outcome group in the univariate analyses (Table 1). In 
the multivariate analysis adjusting for hypertension, atrial fibrilla-
tion, NIHSS, initial occlusion site, initial IAT modality and suc-
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Figure 2. Correlation between the GRAVES and ASPECTS.
Table 1. Baseline characteristics and factors associated with favorable outcome
Total (n= 94) Favorable outcome (n= 44) Unfavorable outcome (n= 50) P
Sex (male) 54 (57.4) 29 (65.9) 25 (50.0) 0.120
Age (year) 68.7± 10.3 68.0± 9.3 69.4± 11.1 0.498
Previous cerebrovascular accident 39 (41.5) 18 (40.9) 21 (42.0) 0.915
Diabetes Mellitus 27 (28.7) 13 (29.5) 14 (28.0) 0.869
Hypertension 58 (61.7) 21 (47.7) 37 (74.0) 0.009
Hypercholesterolemia 41 (43.6) 19 (43.2) 22 (44.0) 0.936
Smoker 15 (16.0) 8 (18.2) 7 (14.0) 0.581
Atrial fibrillation 46 (48.9) 15 (34.1) 31 (62.0) 0.007
Initial NIHSS  16 (12-20) 13 (11-18) 18 (14-21) 0.001
Occlusion site 0.021
   Internal carotid artery 43 (45.9) 16 (36.4) 27 (55.0)
   Middle cerebral artery M1 34 (36.2) 15 (34.1) 19 (38.0)
   Middle cerebral artery M2 17 (18.1) 13 (29.5) 4 (8.0)
IV tPA 58 (61.2) 30 (68.2) 28 (56.0) 0.225
Intra-arterial therapy (IAT) modality 0.012
   Urokinase 46 (48.9) 19 (43.2) 27 (54.0)
   Penumbra 7 (7.4) 0 (0.0) 7 (14.0)
   Solitaire 36 (38.3) 23 (52.3) 13 (26.0)
   Other 5 (5.3) 2 (4.5) 3 (6.0)
Successful reperfusion* 59 (62.8) 34 (77.3) 25 (50.0) 0.006
Alberta Stroke Program Early CT Score (ASPECTS) 8 (6-9) 9 (7-10) 6 (3-9) < 0.001
Gray-matter Volume Estimate Score (GRAVES) 6.2 (2.4-13.8) 3.9 (1.6-6.4) 11.1 (5.0-20.3) < 0.001
Data are presented with number (%), mean± standard deviation, or median (interquartile range [IQR]). 
*Successful reperfusion was defined as Thrombolysis in Cerebral Infarction grade 2b or 3.
NIHSS, National Institutes of Health Stroke Scale; IV tPA, intravenous tissue plasminogen activator.
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cessful reperfusion, not only ASPECTS (Odds Ratio [OR], 
1.401; 95% Confidence Interval [CI], 1.070-1.833; P = 0.014), 
but also GRAVES (OR, 0.878; 95% CI, 0.795-0.970; P = 0.011) 
were independently associated with a favorable outcome.
ROC comparison analysis showed that the predictive value of 
GRAVES for favorable outcome (area under curve [AUC], 
0.765; 95% CI, 0.666-0.846) was not significantly different from 
that of ASPECTS (AUC, 0.717; 95% CI, 0.615-0.805; 
P = 0.308; Figure 3A). The optimal cutoff value of ASPECTS to 
predict a favorable outcome was > 7 (Youden index, 0.37; Sen-
sitivity, 72.7%; Specificity, 64.0%), while that of GRAVES was 
≤ 6.5 (Youden index, 0.47; Sensitivity, 77.3%; Specificity, 
70.0%). When we performed ROC comparison analysis for 
only 59 patients with successful reperfusion, the predictive value 
of GRAVES for a favorable outcome (AUC, 0.762; 95% CI, 
0.634-0.862) was similar to that of ASPECTS (AUC, 0.744; 
95% CI, 0.613-0.848; P = 0.776; Figure 3B). The predictive val-
ue of a multivariate model for a favorable outcome including 
GRAVES (with age, sex, hypertension, atrial fibrillation, initial 
occlusion site, NIHSS, Solitaire, and successful reperfusion; 
AUC, 0.899; 95% CI, 0.819-0.951) was similar to that of a mul-
tivariate model including ASPECTS (AUC, 0.907; 95% CI, 
0.829-0.957; P = 0.552; Figure 3C). 
Reliability of GRAVES and ASPECTS
Linear-weighted κ of ASPECTS was 0.662 (95% CI, 0.595-
0.728). ICC of ASPECTS was 0.895 (95% CI, 0.822-0.935). 
ICC of GRAVES was 0.978 (95% CI, 0.966-0.985). ICC com-
parison analysis revealed that inter-rater agreement of GRAVES 
was significantly better than that of ASPECTS (P < 0.001). 
Bland-Altman plot showed that the mean difference between 
two measures of GRAVES was 0.4 (95% limits of agreement, 
-3.1-4.0) and that of ASPECTS was 0.5 (95% limits of agree-
ment, -2.3-3.2). There were no significant trend between the 
difference and the mean of two measures for both GRAVES 
and ASPECTS (Figure 4).
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Figure 3. Receiver operating characteristic curves of the GRAVES and ASPECTS to predict favorable outcome. (A) Univariate model. (B) Univariate model with suc-
cessfully reperfused patients only. (C) Multivariate model (adjusted for age, sex, hypertension, atrial fibrillation, and initial occlusion site).
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Figure 4. Bland-Altman plot demonstrating the differences between the two measures of the GRAVES and ASPECTS. Differences are plotted against the mean of 
two measures. The solid line indicated the mean of the difference; the dotted lines do the upper and lower 95% limits of agreement.
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Discussion
A rapid, easy, and reliable determination of irreversibly dam-
aged brain tissue is critical in selecting candidates for reperfusion 
therapy in acute stroke patients. Occlusion of the cerebral artery 
causes a decrease in cerebral blood flow to the downstream ter-
ritory, which subsequently results in deprivation of glucose and 
oxygen, depletion of adenosine triphosphate, changes in ionic 
homeostasis, intracellular accumulation of water, and cell death 
in the core region of ischemia. As HU of CT is inversely corre-
lated with the amount of water, an area of low-density lesion 
represents an irreversibly damaged area with cytotoxic edema.1,2 
Irreversible damage is usually more prominent in the gray mat-
ter during the very early stage of infarction because gray matter 
is more vulnerable to ischemic insult compared to white mat-
ter.21 Classic early CT signs detailed in the literature including 
loss of insular ribbon, obscuration of lentiform nucleus and loss 
of gray-white matter differentiation2 all imply ischemic insult of 
gray matter. Thus, we have devised a simple method to quantify 
the extent of EIC by calculating the estimated percentage of hy-
podense lesion in the gray matter of the symptomatic hemi-
sphere. To reflect individual difference of density in the gray 
matter, we calculated mean HU of contralateral caudate head 
and used it as a reference value of estimated normal gray matter. 
While the means of HU in caudate head were different in each 
patient, the standard deviations were relatively consistent be-
tween 4 and 5. Therefore, we defined the range of reference rep-
resenting normal gray matter as pixels of which HU are between 
the mean HU of the contralateral caudate head (HUcaudate) and 
HUcaudate+9 which accounts for two standard deviations. We 
chose the caudate head because it is relatively easy to distinguish 
and usually not affected by bone-induced streak artifact. The 
area of which HU is within the individually defined thresholds 
is not exclusively limited to normal gray matter. However, the ar-
eas of which HU is within the thresholds outside of normal gray 
matter is relatively small and symmetric between the hemi-
spheres, and we operationally define the area of which HU is 
within the thresholds as the estimated area of normal gray mat-
ter. In addition, the estimated areas of normal brain parenchyme 
in each hemisphere were used for adjustment because the nor-
mal volume of the bilateral gray matter could be asymmetrical. 
While the thresholds of the normal gray matter were defined in-
dividually, lower and upper thresholds of HU for normal brain 
parenchyme were predefined as 20 and 55 respectively to enable 
rapid measurement. 
It was not surprising that GRAVES was well correlated with 
ASPECTS given the fundamental principle of both GRAVES 
and ASPECTS, which were designed to estimate the EIC in the 
gray matter. Outcome predictability of GRAVES was also similar 
to that of ASPECTS, not only in the univariate model and the 
multivariate model, but also in the univariate model with success-
fully reperfused patients. GRAVES may also be used for patient 
selection of reperfusion treatment as ASPECTS is. However, fur-
ther external validation studies are required to use GRAVES for 
this purpose in clinical practice. Optimal cutoff value of AS-
PECTS for predicting favorable outcome was > 7 in this study, 
which was consistent with previously reports.7 Although further 
validation is required, GRAVES ≤ 6.5 was the optimal cutoff val-
ue for predicting favorable outcome in this study. 
When calculating GRAVES with computer software, raters 
need only to select the range of CT slices to analyze, adjust the 
central line to separate the hemispheres, and draw ROI on the 
contralateral caudate head, which can usually be done approxi-
mately within 3 minutes. Thus, raters who have a basic under-
standing of brain anatomy can measure GRAVES without diffi-
culty and inter-rater agreement of GRAVES was excellent. 
Compared to ASPECTS which requires certain level of exper-
tise, GRAVES may have an advantage in this regard.
This study has several limitations. First, selection bias is un-
avoidable considering that this study was a retrospective analysis 
of an IAT cohort and the sample size was only modest. Second, 
GRAVES could not be measured in patients with previous in-
farction or other structural lesions in the contralateral gray mat-
ter because it presumes the normality of the contralateral hemi-
sphere. It was also sensitive to motion artifact. In this study, 12 
patients with old territorial infarction and 10 patients with severe 
motion artifact who otherwise met inclusion criteria were ex-
cluded. Third, GRAVES is only applicable to patients with ante-
rior circulation infarction. 
Conclusions
GRAVES has a good correlation with ASPECTS. GRAVES 
was as good as ASPECTS in predicting a favorable clinical out-
come, but was better than ASPECTS with regard to inter-rater 
agreement in patients who received IAT. Although further vali-
dation with larger sample size date is required, GRAVES and 
ASPECTS might be used interchangeably or alternatively to 
predict outcomes and aid the selection of patients for reperfu-
sion therapies. 
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